FAM
JAZZ icon

Fred Alger Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fred Alger Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Sell
1,182
-624
-35% -$109K ﹤0.01% 417
2025
Q4 		$307K Sell
1,806
-387
-18% -$59.3K ﹤0.01% 428
2025
Q3 		$289K Sell
2,193
-64
-3% -$7.68K ﹤0.01% 423
2025
Q2 		$240K Buy
2,257
+410
+22% +$44.5K ﹤0.01% 426
2025
Q1 		$229K Buy
+1,847
New +$241K ﹤0.01% 411
2022
Q4 		– Sell
-17,746
Closed -$2.37M – 542
2022
Q3 		$2.37M Sell
17,746
-88,770
-83% -$13.5M 0.01% 328
2022
Q2 		$16.6M Buy
106,516
+84,786
+390% +$13.1M 0.08% 180
2022
Q1 		$3.38M Buy
+21,730
New +$3.15M 0.01% 305
2018
Q3 		– Sell
-6,000
Closed -$1.03M – 562
2018
Q2 		$1.03M Buy
+6,000
New +$981K ﹤0.01% 323
2016
Q4 		– Sell
-21
Closed -$3K – 503
2016
Q3 		$3K Sell
21
-7,397
-100% -$997K ﹤0.01% 485
2016
Q2 		$1.05M Sell
7,418
-104
-1% -$15.3K 0.01% 322
2016
Q1 		$982K Sell
7,522
-1,712
-19% -$213K 0.01% 377
2015
Q4 		$1.3M Sell
9,234
-2,999
-25% -$416K 0.01% 363
2015
Q3 		$1.63M Sell
12,233
-32,488
-73% -$5.59M 0.01% 359
2015
Q2 		$7.87M Sell
44,721
-70,450
-61% -$12.7M 0.04% 253
2015
Q1 		$19.9M Sell
115,171
-22,135
-16% -$3.8M 0.09% 167
2014
Q4 		$22.5M Sell
137,306
-14,017
-9% -$2.33M 0.11% 168
2014
Q3 		$24.3M Sell
151,323
-8,646
-5% -$1.33M 0.12% 152
2014
Q2 		$23.5M Buy
159,969
+8,785
+6% +$1.22M 0.12% 167
2014
Q1 		$21M Buy
+151,184
New +$22.8M 0.1% 199

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fred Alger Management's JAZZ Position: Q1 2026 in Review

Fred Alger Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 35% in Q1 2026, selling an estimated $109K and leaving 1,182 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Fred Alger Management first reported a position in JAZZ in Q1 2014 and has held it in 20 quarters since. The position peaked at $24.3M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fred Alger Management held 1,182 shares of Jazz Pharmaceuticals worth $223K as of Q1 2026.
  • Fred Alger Management sold 624 Jazz Pharmaceuticals shares in Q1 2026, an estimated $109K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #417 holding.
  • Fred Alger Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 20 quarters since.
  • Fred Alger Management's Jazz Pharmaceuticals position peaked at $24.3M in Q3 2014.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.